Hm Payson & CO Baxter International Inc Transaction History

Hm Payson & CO

$5.6 Billion
Q1 2025

A detailed history of Hm Payson & CO transactions in Baxter International Inc stock. As of the latest transaction made, Hm Payson & CO holds 3,946 shares of BAX stock, worth $125,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,946

Previous 14,848 73.42%

Holding current value

$125,167

Previous $432,000 68.75%

% of portfolio

0.0%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$29.26 - $36.57 $318,992 - $398,686	-10,902 Reduced 73.42%	3,946 $135,000
Q4 2024 Feb 07, 2025	BUY	$28.63 - $37.84 $267,976 - $354,182	9,360 Added 170.55%	14,848 $432,000
Q3 2024 Oct 28, 2024	SELL	$32.85 - $40.26 $41,588 - $50,969	-1,266 Reduced 18.74%	5,488 $208,000
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $38,194 - $50,605	-1,162 Reduced 14.68%	6,754 $225,000
Q1 2024 Jun 20, 2024	SELL	$37.88 - $43.77 $134,474 - $155,383	-3,550 Reduced 30.96%	7,916 $338,000
Q4 2023 Feb 13, 2024	SELL	$31.71 - $38.95 $371,228 - $455,987	-11,707 Reduced 50.52%	11,466 $443,000
Q3 2023 Nov 06, 2023	SELL	$37.32 - $49.29 $17,913 - $23,659	-480 Reduced 2.03%	23,173 $874,000
Q2 2023 Jul 17, 2023	SELL	$39.98 - $47.68 $224,407 - $267,627	-5,613 Reduced 19.18%	23,653 $1.08 Million
Q1 2023 Apr 18, 2023	SELL	$37.58 - $52.57 $80,007 - $111,921	-2,129 Reduced 6.78%	29,266 $1.19 Million
Q4 2022 Feb 06, 2023	SELL	$49.7 - $57.71 $60,783 - $70,579	-1,223 Reduced 3.75%	31,395 $1.6 Million
Q3 2022 Oct 25, 2022	SELL	$53.86 - $66.8 $19,120 - $23,714	-355 Reduced 1.08%	32,618 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $168,255 - $210,880	-2,636 Reduced 7.4%	32,973 $2.12 Million
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $176,370 - $205,287	-2,295 Reduced 6.05%	35,609 $2.76 Million
Q4 2021 Feb 15, 2022	SELL	$74.57 - $87.19 $245,484 - $287,029	-3,292 Reduced 7.99%	37,904 $3.25 Million
Q3 2021 Nov 30, 2021	SELL	$73.77 - $83.61 $46,106 - $52,256	-625 Reduced 1.49%	41,196 $3.31 Million
Q2 2021 Aug 17, 2021	SELL	$80.5 - $88.01 $419,083 - $458,180	-5,206 Reduced 11.07%	41,821 $3.37 Million
Q1 2021 Jun 15, 2021	SELL	$76.38 - $86.03 $75,387 - $84,911	-987 Reduced 2.06%	47,027 $3.97 Million
Q4 2020 Mar 10, 2021	SELL	$75.39 - $82.36 $115,195 - $125,846	-1,528 Reduced 3.08%	48,014 $3.85 Million
Q3 2020 Dec 21, 2020	SELL	$78.33 - $90.73 $61,489 - $71,223	-785 Reduced 1.56%	49,542 $3.98 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $200,347 - $239,774	2,547 Added 5.33%	50,327 $4.33 Million
Q1 2020 Jul 01, 2020	SELL	$71.57 - $93.3 $99,840 - $130,153	-1,395 Reduced 2.84%	47,780 $3.88 Million
Q4 2019 Feb 18, 2020	SELL	$76.7 - $88.45 $16,337 - $18,839	-213 Reduced 0.43%	49,175 $4.11 Million
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $16,605 - $18,315	-204 Reduced 0.41%	49,388 $4.32 Million
Q2 2019 Aug 15, 2019	SELL	$73.44 - $82.41 $94,664 - $106,226	-1,289 Reduced 2.53%	49,592 $4.06 Million
Q1 2019 Jul 31, 2019	BUY	$64.48 - $81.31 $3.22 Million - $4.06 Million	49,881 Added 4988.1%	50,881 $4.14 Million
Q4 2018 Feb 15, 2019	SELL	$61.45 - $77.8 $3.08 Million - $3.9 Million	-50,180 Reduced 98.05%	1,000 $66,000
Q3 2018 Nov 30, 2018	SELL	$70.71 - $77.75 $159,946 - $175,870	-2,262 Reduced 4.23%	51,180 $3.95 Million
Q2 2018 Aug 27, 2018	SELL	$63.43 - $75.41 $60,321 - $71,714	-951 Reduced 1.75%	53,442 $3.95 Million
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $6,068 - $7,009	-97 Reduced 0.18%	54,393 $3.54 Million
Q4 2017 Feb 16, 2018	BUY	$61.45 - $66.05 $149,446 - $160,633	2,432 Added 4.67%	54,490 $3.52 Million
Q3 2017 Nov 06, 2017	BUY	$59.5 - $64.61 $3.1 Million - $3.36 Million	52,058	52,058 $3.27 Million

Others Institutions Holding BAX

# of Institutions

963

Shares Held

470M

Call Options Held

3.84M

Put Options Held

2.32M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account